Publications
- The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 20082013 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- Cost of multiple sclerosis in the Czech Republic: The COMS study2012 | Third Faculty of Medicine, First Faculty of Medicine
- Rare diseases in terms of pharmacoeconomics2012 | Publication without faculty affiliation
- Transferability of National Institute for Health and Clinical Excellence recommendations for pharmaceutical therapies in oncology to Central-Eastern European countries2012 | Publication without faculty affiliation
- Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries2012 | Publication without faculty affiliation
- Pharmacoeconomic aspects of prevention and treatment of osteoporosis2009 | Third Faculty of Medicine
- Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia2006 | Third Faculty of Medicine
- BIOREP - Biologic/Targeted Therapy Registry: 2022 Summary Report2023 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
- Dupilumab for the treatment of atopic dermatitis: Real-world data from the Czech Republic BIOREP registry2022 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
- Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry2022 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
Loading network view...